European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical genetics<br />
eight patients associates early psychomotor development delay with<br />
predominant cognitive defects, autistic features and epilepsy. Their<br />
values of hyperprolinemia ranged from 400 to 2200 µmol/L. Patients<br />
with biallelic PRODH alterations resulting in severely impaired POX<br />
activity had an early onset and severe neurological features. Thus,<br />
children with this phenotype and those with a microdeletion in chromosome<br />
22q11, especially those with mental retardation and autistic features,<br />
should be tested for hyperprolinemia. Hyperprolinemic patients<br />
should be screened for PRODH mutations<br />
P0142. A novel mutation L324V in the fibroblast growth factor<br />
receptor 3 in familial hypochondroplasia<br />
C. Collet 1 , A. Verloes 2 , M. Lenne 1 , J. L. Laplanche 1 ;<br />
1 Service de biochimie et biologie moléculaire, Hôpital Lariboisière, Paris, France,<br />
2 Unité fonctionnelle de génétique clinique, Fédération de génétique, Hôpital<br />
Robert Debré, Paris, France.<br />
Hypochondroplasia is an autosomal dominant skeletal dysplasia characterized<br />
by short-limb dwarfism with rhizomelic shortening. This phenotype<br />
is similar to achondroplasia, but the features tend to be milder,<br />
as macrocephaly with relatively normal facies. Diagnosis is made by<br />
careful physical examination and x-rays. The diagnosis is also often<br />
made later in childhood (2-4 years of age). Before three years of age,<br />
the diagnosis is difficult, as skeletal disproportion tends to be mild and<br />
many of the radiographic features are subtle during infancy. Its incidence<br />
is 1:30000 live births. Actually, about 80 percent of hypochondroplasia<br />
cases are caused by heterozygous mutations in the FGFR3<br />
gene, unique gene known to be associated with hypochondroplasia.<br />
Two recurrent mutations in exon 13, c.<strong>16</strong>20C>G or c.<strong>16</strong>20C>A, resulting<br />
in an p.N540K substitution in the proximal tyrosine kinase domain<br />
represent ~ 60% of all cases of hypochondroplasia. Sequence analysis<br />
of others FGFR3 exons detects rare mutations. We report a new<br />
heterozygous mutation in exon 9 of FGFR3, p.L324V, c. 970C>G, in<br />
a familial hypochondroplasia. The father and his son presented mild<br />
phenotype with a more severe expression in the father than in his son.<br />
This mutation, not reported as SNP, is located in the third immunoglobulin<br />
(Ig)-like domain, in a highly conserved tripeptide sequence residue<br />
within the FGFR family. This result strongly suggests that p.L324V mutation<br />
is responsible for hypochondroplasia.<br />
P0143. Dental symptoms - clue to the diagnosis of<br />
hypophosphatasia of childhood type<br />
B. Tumiene 1 , A. Utkus 1 , R. Cerkauskiene 2 , K. Becker 3 , W. Reardon 4 , R. Janavicius<br />
1 , J. Songailiene 1 , L. J. M. Spaapen 5 , V. Kucinskas 1 ;<br />
1 Department of <strong>Human</strong> and Medical <strong>Genetics</strong>, Vilnius, Lithuania, 2 Vilnius<br />
University Children’s hospital, Vilnius, Lithuania, 3 North Wales Clinical <strong>Genetics</strong><br />
Service, Glan Clwyd Hospital, North Wales, United Kingdom, 4 Our Lady’s<br />
Hospital for Sick Children, Crumlin, Ireland, 5 Dept. of Biochemical <strong>Genetics</strong>,<br />
Academic Hospital Maastricht, Maastricht, The Netherlands.<br />
Hypophosphatasia is an inherited disorder characterized by defective<br />
bone and teeth mineralization. The disease is due to mutations in the<br />
ALPL gene. Variable clinical expression of the disease ranging from<br />
stillbirth to pathologic skeletal fractures in adult years reflects allelic<br />
heterogeneity in this disease.<br />
Our presented patient is a 4 year old female with uneventful pre- and<br />
postnatal history until the age of 3 months. A head deformity was noticed<br />
at that time (turricephaly) and progressed thereafter with premature<br />
closure of cranial sutures and fontanelles. Increased intracranial<br />
pressure developed and became symptomatic (bulging fontanelle,<br />
bilateral edema of optical nerve, exophthalmos, prominent subcutaneous<br />
veins, nausea and vomiting). Skeletal symptoms appeared at<br />
about 6 months of age with the signs of rickets and waddling gait.<br />
Dental symptoms included delayed eruption of deciduous teeth (the<br />
first at 9 months of age), premature loss of both incisors and later additional<br />
6 teeth and severe caries. These dental symptoms specifically<br />
pointed to a possible diagnosis of hypophosphatasia. Additional signs<br />
were small stature and muscular hypotony. Biochemical assays revealed<br />
low-normal serum alkaline phosphatase (37.3 UI/l, n.35-281 UI/<br />
l), significant hyperphosphaturia (fractional excretion <strong>19</strong>.1→24.8 %),<br />
and low serum intact parathormone (1-6 pg/ml, n.10-69 pg/ml). Clearly<br />
increased phosphoetanolamine in urine was detected (152 μmol/mmol<br />
creat., n.0-21 μmol/mmol creat), plasma pyridoxal 5’-phosphate was<br />
also highly elevated (1233 nmol/l, ref.